Arformoterol/Ciclesonide

阿福特罗/环索奈德

Report date: 2025/11/18 14:49:21

Base Information

Drug NameArformoterol/Ciclesonide
Drug Alias NameArformoterol+Ciclesonide阿福特罗+环索奈德环索奈德+阿福特罗Ciclesonide+ArformoterolCiclesonide/Arformoterol +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Arformoterol TartrateCiclesonide
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A